(Q51037574)

27 March 2018

title

Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome. (English)

1 reference

27 March 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

Sawaek Weerakiet

1

1 reference

27 March 2018

Areepan Sophonsritsuk

2

1 reference

27 March 2018

Srithean Lertvikool

3

1 reference

27 March 2018

Chonthicha Satirapot

4

1 reference

27 March 2018

Supatra Leelaphiwat

5

1 reference

27 March 2018

Rattiya Jultanmas

6

1 reference

27 March 2018

publication date

26 April 2011

1 reference

27 March 2018

Journal of Obstetrics and Gynaecology Research

published in

1 reference

27 March 2018

volume

37

1 reference

27 March 2018

issue

9

1 reference

27 March 2018

page(s)

1229-1237

1 reference

27 March 2018

Polycystic ovary syndrome: clinical aspects

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Use of metformin in polycystic ovary syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Efficacy of metformin on ovulation induction in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

The role of metformin in polycystic ovary syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Consensus on infertility treatment related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Consensus on infertility treatment related to polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Metformin monotherapy in lean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Use of metformin for ovulation induction in women who have polycystic ovary syndrome with or without evidence of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2010.01507.X

10.1111/J.1447-0756.2010.01507.X

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018